Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723546 | SCV000112659 | uncertain significance | not provided | 2016-10-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000723546 | SCV000718679 | likely benign | not provided | 2021-05-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001088599 | SCV000751584 | likely benign | Duchenne muscular dystrophy | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000080757 | SCV001433474 | likely benign | not specified | 2019-07-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381400 | SCV002668469 | benign | Cardiovascular phenotype | 2021-10-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001826759 | SCV002087774 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2017-08-09 | no assertion criteria provided | clinical testing |